CervoMed Inc.
CRVO
$8.90
-$0.01-0.11%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 9.74M | 10.07M | 9.65M | 8.08M | 7.14M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.74M | 10.07M | 9.65M | 8.08M | 7.14M |
| Cost of Revenue | 15.03M | 10.79M | 7.46M | 7.46M | 6.48M |
| Gross Profit | -5.29M | -728.10K | 2.19M | 623.10K | 664.70K |
| SG&A Expenses | 9.17M | 8.97M | 9.17M | 7.65M | 6.52M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 27.97M | 23.53M | 20.40M | 17.07M | 14.96M |
| Operating Income | -18.23M | -13.47M | -10.75M | -8.98M | -7.81M |
| Income Before Tax | -16.29M | -11.95M | -5.04M | -4.15M | -2.17M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -16.29 | -11.95 | -5.04 | -4.15 | -2.17 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -16.29M | -11.95M | -5.04M | -4.15M | -2.17M |
| EBIT | -18.23M | -13.47M | -10.75M | -8.98M | -7.81M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -1.99 | -1.60 | -0.40 | -2.89 | -3.51 |
| Normalized Basic EPS | -1.24 | -1.00 | -0.25 | -1.80 | -2.19 |
| EPS Diluted | -1.99 | -1.60 | -1.75 | -4.23 | -4.86 |
| Normalized Diluted EPS | -1.24 | -1.00 | -0.30 | -1.85 | -2.24 |
| Average Basic Shares Outstanding | 32.28M | 29.85M | 24.45M | 16.27M | 10.61M |
| Average Diluted Shares Outstanding | 32.28M | 29.85M | 24.91M | 16.73M | 11.07M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |